Study of CBP-1019 with chemo for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called CBP-1019 combined with chemotherapy (FOLFOX) and possibly other drugs for people with advanced solid tumors that have stopped responding to standard treatments. It may be an option if you have a type of cancer that hasn't gotten better with other therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor cancer that has spread or cannot be removed, and standard treatments are no longer working.
- You have received at least one prior line of standard chemotherapy.
- You are 18 years or older and willing to sign a consent form.
- You must have adequate organ function, like normal blood counts, liver and kidney function.
- You must agree to use effective birth control during the study and for 6 months after.
- You must provide a tumor sample from a prior biopsy or agree to a new biopsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called FG-B901, either alone or with chemotherapy, for people with advanced solid tumors that haven't responded to standard treatment. The goal is to see if the drug can shrink tumors or slow their growth.
This study tests a new drug, CRB-601-01, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and can help shrink tumors.
This study tests an experimental drug called CT3001 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it's safe and effective, and for some patients with colorectal cancer, it may be combined with standard chemotherapy.
This trial tests a new drug, HEC-921, given alone or with other cancer treatments for people with advanced solid tumors. It may be an option for those who have tried standard treatments or who have a specific marker on their tumor.
This trial tests a combination of two new drugs (QLS31905 and/or QL1706) with chemotherapy for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if this combination can shrink tumors and help people live longer.
This trial tests a new combination treatment (HC010) for people with advanced solid tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.